Magnetic nanoparticles (MNPs) have emerged as a versatile platform in cancer nanomedicine, owing to their unique physicochemical properties, including high surface‐to‐volume ratios, superparamagnetism, and intrinsic biocompatibility. These features enable multifunctional applications spanning targeted drug delivery, co...
Shivani Kadam, Rahul M. Sonavale, Ratnesh Das et al.· Nano Select· 0 citations
Overall, polymer-metal hybrid nanoparticles represent a versatile and promising nanomedicine platform for precision breast cancer management, with continued advances in nanoparticle engineering, safety assessment, and clinical validation expected to facilitate their successful translation into personalized oncology.
Pranoti A. Mane, A. Mohite, K. Datkhile et al.· Cureus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.